Brief: Medical Marijuana, Inc. Investment Company Axim Biotechnologies To Acquire Sapphire Biotech
09/01/2020 14:17
Jan 9 (Reuters) - Axim Biotechnologies Inc AXIM.PK :
* MEDICAL MARIJUANA, INC. INVESTMENT COMPANY AXIM
BIOTECHNOLOGIES
TO ACQUIRE LEADING ONCOLOGY RESEARCH AND DEVELOPMENT COMPANY
SAPPHIRE BIOTECH, INC.
Source text for Eikon: ID:nPn5qKHFca
Further company coverage: AXIM.PK
((Briefs@thomsonreuters.com;))
Recent news on Medical Marijuana
See all newsUS Supreme Court rejects medical marijuana firm's bid to avoid racketeering suit (updated)
US Supreme Court rejects medical marijuana firm's bid to avoid racketeering suit
US Supreme Court hears case of trucker fired for failed drug test from cannabis-based CBD
Brief: Medical Marijuana Appoints Dr Timothy Scott as CEO
Brief: Medical Marijuana Inc Reports $9.2 Mln In Net Revenue In 2021 Third Quarter Financial And Operational Results